comparemela.com

Latest Breaking News On - Cytopheretic device - Page 1 : comparemela.com

SeaStar Medical Receives FDA Approval to Begin Study with

Patient enrollment in pivotal clinical study expected to begin in March DENVER, Feb. 09, 2023 (GLOBE NEWSWIRE) SeaStar Medical (Nasdaq: ICU), a.

United statesJody cainKevin chungPatty caballeroDrug administrationSeastar medical incStar medicalSelective cytopheretic devicePre market approvalChief medical officerDevice designationSeastar medicalPrivate securities litigation reform actNasdaq icuSeastar medical holding corporationSeastar medical

SeaStar Medical Appoints Dr Sai Prasad Iyer, Ph D as VP, Medical Affairs and Clinical Development

19.09.2022 - Denver, Colo. and Tampa, Fla., Sept. 19, 2022 (GLOBE NEWSWIRE) - SeaStar Medical, a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, and LMF Acquisition Opportunities, . Seite 1

United statesPrasadn iyerClinical development at seastarCompany medical affairsAcquisition opportunities incStar medicalSai prasadVice presidentMedical affairsClinical developmentSeastar medicalCytopheretic device

SeaStar Medical Appoints Kevin Chung, MD as Chief Medical

Dr. Chung is a renowned critical care physician, research and thought leader in extracorporeal life support therapies.

United statesFort gordonNatalya rudmanKevin chungPatty caballeroBrucem rodgersEric schlorffUniformed services universityUnited states military academy at west pointCrescendo communicationsUnited states army institute of surgical researchAcquisition opportunities incExchange commissionGeorgetown university school of medicineDwightd eisenhower army medical centerBrooke army medical center

vimarsana © 2020. All Rights Reserved.